Filters

anti-Muscarinic acetylcholine receptor M3 (3rd Cytopl. Dom.) Antibody

anti-Muscarinic acetylcholine receptor M3 (3rd Cytopl. Dom.) Antibody size: 50 Ð’µg 732

Supplier ACR
Price 732
Size 50 Ð’µg
Vial descriptionCHRM3
Categoryprimary antibody
Clonalitypolyclonal
Raised inRabbit
Clone1 vial
FormAffinity Purified
Reactivity , Chicken, Dog, Guinea Pig, Horse, Human, L, Monkey, Mouse, Oporcinerimate, Rabbit, Rat, Tr, Bovine
Puritypurified
Molecular weightin kDa
Sourcemammalian
Activityto be determined
Rangebroad
Protein numberP20309
ApplicationELISA
Storage Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4°
Description 2 or 3 and , Freeze thaw will destroy a percentage in every cycle and should be avoided, However, In this sense, The receptors are ligand binding factors of type 1, When such chemical-signals couple or bind to a receptor, a change in the electrical-activity of a cell, acetylcholine, am olfactory receptor is a protein-molecule that recognizes and responds to , an acetylcholine-receptor recognizes and responds to its endogenous-ligand, chemokinesor cytokines e, e, sometimes in pharmacology, such as enzymes, the term is also used to include other proteins that are drug-targets, they cause some form of cellular/tissue-response, transporters and ion-channels, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4°, endogenous-chemical signals, g, g, protein-molecules , that receive chemical-signals from outside a cell
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24°
Gene target Dom, Muscarinic acetylcholine receptor M3 (3rd Cytopl
Short name Dom, ) Antibody, anti-Muscarinic acetylcholine receptor M3 (3rd Cytopl
Technique antibodies against human proteins, antibodies for, antibody to, Antibody
Alternative name Dom, ) (Antibody to), antibody to-Muscarinic acetylcholine receptor M3 (3rd Cytopl
Alternative techniqueantibodies

Subscribe to our Newsletter